CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 165 filers reported holding CARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $530 | +52900.0% | 108 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 108 | -41.9% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 186 | +181.8% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 66 | +34.7% | 0.00% | – |
| Q4 2021 | $1,000 | -100.0% | 49 | -80.4% | 0.00% | – |
| Q3 2018 | $5,988,000 | +25.1% | 250 | 0.0% | 0.00% | – |
| Q2 2018 | $4,788,000 | +54.7% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $3,095,000 | +1.1% | 250 | 0.0% | 0.00% | – |
| Q4 2017 | $3,060,000 | -10.6% | 250 | 0.0% | 0.00% | – |
| Q3 2017 | $3,423,000 | +48.2% | 250 | +66.7% | 0.00% | – |
| Q2 2017 | $2,309,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
| Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
| FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
| Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
| PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
| PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
| Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
| XTX Topco Ltd | 52,025 | $147,231 | 0.03% |